Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2022-06-23

Clinical Trial Update: A Comparison of Dexamethasone and Triamcinolone for Ultrasound-guided Occipital C2 Nerve Blocks [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing dexamethasone versus triamcinolone for occipital C2 nerve blocks was withdrawn. No results reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)
  • Triamcinolone (triamcinolone)

Snippet

Sponsor: Northwestern University | Conditions: Headache | Phase 4 | Status: WITHDRAWN